CN115724825A - Acridine phenyl phenanthroimidazole compound for preparing luminescent layer of electroluminescent device and preparation method thereof - Google Patents

Acridine phenyl phenanthroimidazole compound for preparing luminescent layer of electroluminescent device and preparation method thereof Download PDF

Info

Publication number
CN115724825A
CN115724825A CN202210939882.2A CN202210939882A CN115724825A CN 115724825 A CN115724825 A CN 115724825A CN 202210939882 A CN202210939882 A CN 202210939882A CN 115724825 A CN115724825 A CN 115724825A
Authority
CN
China
Prior art keywords
phenyl
acridine
compound
phenanthroimidazole
halogenated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210939882.2A
Other languages
Chinese (zh)
Inventor
侯佳男
吉冯春
张一鹏
许辉
陈硕
李海东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heilongjiang University
Original Assignee
Heilongjiang University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heilongjiang University filed Critical Heilongjiang University
Priority to CN202210939882.2A priority Critical patent/CN115724825A/en
Publication of CN115724825A publication Critical patent/CN115724825A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Electroluminescent Light Sources (AREA)

Abstract

The invention provides a luminescent layer of an electroluminescent device, which is prepared by taking an acridine phenyl phenanthroimidazole compound as a raw material. The compound takes phenanthroimidazole as a matrix, introduces acridine phenyl and methoxyphenyl, improves the luminous performance of the compound as a thermal excitation delay luminescent material, and further improves the comprehensive performance of an organic electroluminescent device.

Description

Acridine phenyl phenanthroimidazole compound for preparing luminescent layer of electroluminescent device and preparation method thereof
Technical Field
The invention belongs to the technical field of electroluminescent materials, and particularly relates to an acridine phenyl phenanthroimidazole compound for preparing a luminescent layer of an electroluminescent device and a preparation method thereof.
Background
With the development of information technology, the demand and use requirements of semiconductor devices are increasing. However, the size miniaturization of the inorganic semiconductor memory that is currently mainstream is limited by a large number of materials and cost factors. The development of new memory storage structures and materials is facing new opportunities.
Organic light-emitting diodes (OLEDs) based on traditional fluorescent materials can only emit light by radiation using singlet excitons, the theoretical maximum Internal Quantum Efficiency (IQE) of which is only 25%; the second generation OLEDs of phosphorescent emissive materials based on noble metals, which have been developed later, accelerate the intersystem crossing process due to the heavy atom effect, so that the radiation of triplet excitons becomes possible, theoretically, the complete utilization of excitons can be achieved, and IQE can reach 100%. However, the phosphorescent emitting materials based on noble metals are expensive and triplet-triplet quenching occurs at high current, resulting in a large roll-off in device efficiency.
Organic molecules of thermally-excited delayed fluorescence (TADF) nature are generally donor-acceptor type molecules and have small triplet and singlet energies that are very poor. The small singlet state and triplet state energy range difference can convert triplet state electrons into singlet state electrons, thereby improving the utilization rate of electrons and realizing 100% internal quantum efficiency. However, at high concentrations, electron annihilation occurs, reducing efficiency.
Therefore, organic thermal excitation delayed fluorescence aromatic phosphine oxide materials are further researched, so that the electroluminescent device has good electron transmission capacity, current efficiency, power efficiency, external quantum efficiency and efficiency stability, the electroluminescent comprehensive performance is good, and the practical use requirements are met.
Disclosure of Invention
In order to solve the problems, the invention provides a luminescent layer of an electroluminescent device, which takes an acridine phenyl phenanthroimidazole compound as a raw material, introduces an acridine phenyl group on phenanthroimidazole to improve the thermal stability and the luminescent property of a molecule, is used as a thermal excitation delay fluorescent material, can be used for preparing the electroluminescent device, and has the advantages of low starting voltage, low energy consumption, high external quantum efficiency, good luminescent purity and effectively improved comprehensive performance, thereby completing the invention.
The invention aims to provide a luminescent layer of an electroluminescent device, which is prepared by taking one or more of acridine phenyl phenanthroimidazole compounds as raw materials,
it is also an object of the present invention to provide an acridinophenylphenanthoimidazole compound having the following structure:
Figure BDA0003785097570000021
wherein R is 1 、R 2 Each independently selected from hydrogen, phenyl or alkyl, preferably from hydrogen, phenyl or a carbon containing number C 1 -C 5 More preferably phenyl or methyl.
The invention also provides a preparation method of the acridine phenyl phenanthroimidazole compound, which comprises the step of preparing the acridine phenyl phenanthroimidazole compound by taking the acridine compound and the halogenated phenyl phenanthroimidazole as raw materials through catalytic coupling.
The method specifically comprises the following steps:
step 1, phenanthrene-9, 10-diketone, 4-methoxyaniline and 4-halogenated-benzaldehyde are added into a solvent I, and condensation cyclization reaction is carried out to obtain 2- (4-halogenated-phenyl) -1- (4-methoxyphenyl) -1H phenanthro [9,10] imidazole.
And 2, adding the 2- (4-halogenated-phenyl) -1- (4-methoxyphenyl) -1H phenanthro [9,10] imidazole and acridine compounds into a solvent II, and carrying out catalytic coupling reaction to obtain a reaction solution.
And 3, post-treating the reaction liquid to obtain the acridine phenyl phenanthroimidazole compound.
The invention also aims to provide the application of the acridine phenyl phenanthroimidazole compound as a luminescent layer material in preparing an electroluminescent device.
The acridine phenyl phenanthroimidazole compound for preparing the luminescent layer provided by the invention has the following beneficial effects:
(1) The invention takes phenanthroimidazole as a parent body, introduces acridine phenyl and methoxyphenyl, improves the hole electron transport property of the molecule, and improves the luminescent property to a certain degree.
(2) The acridine phenyl phenanthroimidazole compound is used as a luminescent layer material, has narrow electroluminescent peak position, is a deep blue light organic luminescent material with high luminescent color purity, and further improves the performance of the luminescent material.
(3) The electroluminescent device prepared by using the acridine phenyl phenanthroimidazole compound as a luminescent layer material has good comprehensive performance, effectively improves brightness, and has stable thermal performance and luminescent performance.
Drawings
FIG. 1 shows a UV spectrum and a fluorescence spectrum of compound I in example 1 of the present invention;
FIG. 2 shows a UV spectrum and a fluorescence spectrum of compound II in example 2 of the present invention;
FIG. 3 shows a thermogravimetric analysis of compound I in example 1 of the present invention;
FIG. 4 shows a thermogravimetric analysis of compound II in example 2 of the present invention;
FIG. 5 is a graph showing the voltage-luminance relationship of an electro-blue light device in example 1 of the present invention;
FIG. 6 shows the voltage-luminance relationship of an electro-blue light device in example 2 of the present invention;
FIG. 7 shows the luminance-current efficiency relationship of an electro-blue light device in example 1 of the present invention;
FIG. 8 is a graph showing the luminance-current efficiency relationship of an electro-blue light device in example 2 of the present invention;
FIG. 9 shows the luminance-power efficiency relationship of an electro-blue light device in example 1 of the present invention;
FIG. 10 is a graph showing the luminance-power efficiency relationship of an electro-blue light device in example 2 of the present invention;
FIG. 11 shows the luminance-external quantum efficiency curve efficiency of an electrogenerated blue light device in example 1 of the present invention;
FIG. 12 shows the luminance-external quantum efficiency curve efficiency of an electroblue device in example 2 of the present invention;
FIG. 13 is a graph showing an electroluminescence spectrum of a blue electroluminescent device in example 1 of the present invention;
FIG. 14 shows the electroluminescence spectrum of a blue electroluminescent device in example 2 of the present invention.
Detailed Description
The present invention will now be described in detail by way of specific embodiments, and features and advantages of the present invention will become more apparent and apparent from the following description.
The invention provides an acridine phenyl phenanthroimidazole compound for preparing a light-emitting layer of an electroluminescent device, which takes phenanthroimidazole as a matrix and introduces acridine phenyl and methoxyphenyl, aims to improve the hole electron transport property of a molecule so as to improve the thermal stability and the light-emitting brightness, is used as a light-emitting layer material to prepare the electroluminescent device, has high light-emitting purity, good thermal stability of the compound, stable performance of indexes such as external quantum efficiency, current efficiency, power efficiency and the like in the using process, has good device brightness, and can meet the use requirements of people.
The invention provides an acridine phenyl phenanthroimidazole compound, which has the following structure:
Figure BDA0003785097570000051
wherein R is 1 、R 2 Each independently selected from hydrogen, phenyl or alkyl, preferably from hydrogen, phenyl or a carbon containing number C 1 -C 5 More preferably phenyl or methyl.
Preferably, the acridine phenyl phenanthroimidazole compound is selected from the following compounds:
Figure BDA0003785097570000061
the acridine phenyl phenanthroimidazole compound can be used as a thermal excitation delayed fluorescence luminescent material, can be used as a luminescent layer material and is used for preparing an electroluminescent device.
The invention also provides a preparation method of the acridine phenyl phenanthroimidazole compound, which takes the acridine compound and the halogenated phenyl phenanthroimidazole as raw materials to prepare the acridine phenyl phenanthroimidazole compound through catalytic coupling.
The halophenyl phenanthroimidazole is 2- (4-halo-phenyl) -1- (4-methoxyphenyl) -1H phenanthro [9,10] imidazole, and is:
Figure BDA0003785097570000062
wherein, X is a halogenated group, preferably bromo, iodo or chloro, more preferably bromo.
The method specifically comprises the following steps:
step 1, phenanthrene-9, 10-diketone, 4-methoxyaniline and 4-halogenated-benzaldehyde are added into a solvent I, and condensation cyclization reaction is carried out to obtain 2- (4-halogenated-phenyl) -1- (4-methoxyphenyl) -1H phenanthro [9,10] imidazole.
The 2- (4-halogenated-phenyl) -1- (4-methoxyphenyl) -1H phenanthro [9,10] imidazole is prepared by condensation cyclization of phenanthrene-9, 10-diketone, 4-methoxyaniline and 4-halogenated-benzaldehyde under an acidic condition.
The 4-halo-benzaldehyde is selected from 4-bromobenzaldehyde, 4-chlorobenzaldehyde or 4-iodo-benzaldehyde, and is preferably 4-bromobenzaldehyde.
The solvent I is selected from one or more of organic acid, amide solvent, ketone solvent and sulfone solvent, preferably one or more of acetic acid, N-Dimethylformamide (DMF), N-Dimethylacetamide (DMA), dimethyl sulfoxide (DMSO), 1, 3-dimethyl-2-imidazolidinone (DMI) and cyclohexanone, and preferably acetic acid.
The molar volume ratio of the 9, 10-phenanthrene diketone to the solvent I is 13.5mmol (30-90) mL, preferably 13.5mmol (40-80) mL, and more preferably 13.5mmol (50-70) mL.
The condensation cyclization reaction is carried out in an acidic solution, and weakly acidic substances, such as ammonium acetate and acetic acid, are added into the reaction solution. The molar ratio of the ammonium acetate to the 9, 10-phenanthrene diketone is 13.5 (30-80), preferably 13.5 (40-70), and more preferably 13.5 (50-60).
The condensation cyclization reaction is carried out under the protective atmosphere, such as nitrogen and argon, and the heat preservation reaction is carried out for 12 to 45 hours, preferably 18 to 36 hours. The reaction temperature is 95 to 145 ℃, preferably 105 to 135 ℃, more preferably 115 to 125 ℃.
After the condensation cyclization reaction is finished, cooling to room temperature, filtering reaction liquid, washing and drying, and then carrying out column purification, wherein the eluent is preferably a mixed solvent of Dichloromethane (DCM) and Petroleum Ether (PE).
And 2, adding the 2- (4-halogenated-phenyl) -1- (4-methoxyphenyl) -1H phenanthro [9,10] imidazole and acridine compounds into a solvent II, and carrying out catalytic coupling reaction to obtain a reaction solution.
The acridine compound is selected from acridine or 9, 9-disubstituted acridine. In the 9, 9-disubstituted acridine, the substituent is selected from phenyl or alkyl, preferably from phenyl or a carbon-containing number C 1 -C 5 More preferably phenyl or methyl.
The molar ratio of the- (4-halogenated-phenyl) -1- (4-methoxyphenyl) -1H phenanthro [9,10] imidazole to the acridine compound is 1 (0.6-2.3), preferably 1 (0.8-1.8), and more preferably 1 (1.0-1.3).
The solvent II is selected from one or more of amide solvents, ketone solvents and aromatic solvents, preferably one or more of N, N-Dimethylformamide (DMF), N-Dimethylacetamide (DMA), toluene, xylene, 1, 3-dimethyl-2-imidazolidinone (DMI) and cyclohexanone, and more preferably xylene.
The molar volume ratio of the acridine compound to the solvent II is 2mmol (15-45) mL, preferably 2mmol (20-40) mL, and more preferably 2mmol (25-35) mL.
In the catalytic coupling reaction, the catalyst is selected from a divalent palladium compound, preferably a palladium salt or a palladium complex, preferably tetrakis (triphenylphosphine) palladium (Pd (PPh) 3 ) 4 ) One or more of palladium chloride, palladium acetate, bis (triphenylphosphine) palladium dichloride, bis (triphenylphosphine) palladium acetate and bis (acetylacetone) palladium, and more preferably palladium acetate or bis (tri-tert-butylphosphine) palladium.
The molar ratio of the acridine compound to the divalent palladium compound is (1.2-3.5): 0.1, preferably (1.5-3.0): 0.1, and more preferably (1.8-2.5): 0.1.
Preferably, a divalent palladium salt (such as palladium acetate) is used in the present invention in the presence of a reducing agent and tri-tert-butylphosphine.
The reducing agent is selected from potassium alkoxide or sodium alkoxide, preferably from potassium tert-butoxide or sodium tert-butoxide. In the invention, the reducing agent is alkaline and can also play a role of an acid binding agent.
The molar ratio of the acridine compound to the reducing agent is 2 (3.5-10.5), preferably 2 (4.5-9), and more preferably 2 (5.5-7.5).
The molar ratio of the divalent palladium salt to the tri-tert-butylphosphine is 1 (0.5-5.5), preferably 1 (1.5-4.5), and more preferably 1 (2.5-3.5).
The reaction is carried out for 10 to 18 hours, preferably 12 to 15 hours under a protective atmosphere. The reaction temperature is 115-150 deg.C, preferably 125-135 deg.C.
And 3, post-treating the reaction liquid to obtain the acridine phenyl phenanthroimidazole compound.
After the reaction was completed, it was cooled to room temperature, the precipitate was filtered off, and the filtrate was washed with brine, dried over anhydrous sodium sulfate, filtered and concentrated to dryness. And purifying the obtained solid by chromatography, wherein the stationary phase is silica gel, the mobile phase eluent is a mixed solution of ethyl acetate and n-hexane, and the volume ratio of the two is 1: and 5, obtaining the acridine phenyl phenanthroimidazole compound.
The acridine phenyl phenanthroimidazole compound prepared by the method has high yield which can reach 80%. The compounds have deep blue electroluminescence, and both can be used as a light emitting layer of a non-doped electroluminescent device for an evaporation device, so that stable deep blue luminescence under high brightness is realized, and the compounds have high luminescent purity, high brightness and stable thermal performance and luminescent performance.
The invention provides application of the acridine phenyl phenanthroimidazole compound as a luminescent layer material in preparation of an electroluminescent device.
The electroluminescent device comprises a conductive anode layer, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron injection layer and a cathode conductive layer.
The invention provides a preparation method of a luminescent device taking carbazole phenyl phenanthroimidazole aromatic phosphine oxide as a luminescent layer material, which specifically comprises the following steps:
1. preparing a conductive anode layer;
the conductive anode layer is prepared on a substrate layer. The conductive anode layer is selected from tin oxide conductive glass (ITO), transparent conductive polymers such as polyaniline, semi-transparent metals such as Au, preferably ITO or semi-transparent metals, more preferably ITO. Preferably, the conductive anode layer is evaporated by vacuum evaporation.
Preferably, the vacuum degree of vacuum deposition is 1X 10 -6 mbar, evaporation rate is set to be 0.1-0.3 nm/s, the evaporation material is indium tin oxide on the glass or plastic substrate, and the thickness of the anode conductive layer is 6-40 nm, preferably 8-30 nm, and more preferably 10-20 nm.
Preferably, the following hole injection layer, hole transport layer, light emitting layer, electron transport layer, electron injection layer and cathode conductive layer are prepared using a vacuum evaporation method.
2. Preparing a hole injection layer;
the hole injection layer is evaporated onto the anode conductive layer to a thickness of 4 to 35nm, preferably 6 to 25nm, more preferably 8 to 15nm, such as 10nm.
The hole injection layer material is selected from molybdenum oxide or poly 3, 4-ethylenedioxythiophene: polystyrene sulfonate (PEDOT: PSS), preferably molybdenum oxide, more preferably molybdenum oxide.
3. Preparing a hole transport layer;
the hole transport layer is evaporated onto the hole injection layer to a thickness of 15-65nm, preferably 25-55nm, more preferably 35-45nm, such as 40nm.
The hole transport layer material is selected from one or more of arylamine compounds and carbazole compounds, such as N, N ' -diphenyl-N, N ' - (1-naphthyl) -1,1' -biphenyl-4, 4' -diamine (NPB) and 9,9' - (1, 3-phenyl) di-9H-carbazole (mCP), and is preferably mCP.
4. Preparing a luminescent layer;
the light-emitting layer is further evaporated on the hole transport layer to a thickness of 35-75nm, preferably 40-65nm, more preferably 45-55nm, such as 50nm.
The light-emitting layer material comprises an aromatic phosphine oxide compound containing diphenylfluorene, preferably, also comprises bis [2- ((oxo) diphenylphosphino) phenyl ] ether (DPEPO), and the mass fraction of the DPEPO in the light-emitting layer material is 10-30%, preferably 15-25%, such as 20%.
5. Preparing an electron transport layer;
the electron transport layer material is selected from tris (8-hydroxyquinoline) aluminum (Alq 3), 1,3, 5-tris (1-phenyl-1H-benzimidazol-2-yl) benzene (TPBi), 4, 7-diphenyl-1, 10-phenanthroline (Bphen), 3- (biphenyl-4-yl) -5- (4-tert-butylphenyl) -4-phenyl-4H-1, 2, 4-Triazole (TAZ) or bis [2- ((oxo) diphenylphosphino) phenyl ] ether (DPEPO), preferably DPEPO. The electron transport layer is evaporated onto the light emitting layer to a thickness of 25 to 55nm, more preferably 35 to 45nm, such as 40nm.
6. Preparing an electron injection layer;
the electron injection layer is evaporated on the electron transport layer to a thickness of 4 to 18nm, preferably 6 to 15nm, more preferably 8 to 12nm, such as 10nm.
The material of the electron injection layer is selected from lithium tetrakis (8-hydroxyquinoline) boron (LiBq) 4 ) Or LiF, preferably LiF.
7. And preparing a cathode conducting layer, and packaging to obtain the thermally-excited delayed fluorescence electroluminescent device.
The cathode conductive layer is evaporated on the electron injection layer to a thickness of 4-20nm, preferably 6-15nm, more preferably 8-12nm, such as 10nm.
The cathode conducting layer material is selected from a single metal cathode or an alloy cathode, such as metal Al.
The acridine phenyl phenanthroimidazole compound provided by the invention has good thermal stability and luminescence property, and can improve electron transport capability in a luminescence layer and optimize device performance when being used as the luminescence layer. The luminescent layer material is applied to the electroluminescent device, so that the high-efficiency blue-light thermally-excited delayed fluorescence device is obtained, the luminous efficiency of the device is greatly improved, and the stability of the luminous efficiency is good.
Examples
Example 1
(1) 4-bromobenzaldehyde (13.5 mmol) and phenanthrene-9, 10-dione (13.5 mmol) are mixed, and then a mixture of 4-bromobenzaldehyde (13.5 mmol) and phenanthrene-9, 10-dione (13.5 mmol), 4-methoxyaniline (67.5 mmol) and ammonium acetate (54.5 mmol) are added to acetic acid (60 mL) under an argon atmosphere, dissolved with stirring and reacted at 120 ℃ for 24 hours.
After the reaction, the reaction mixture was cooled to room temperature, and the reaction mixture was filtered, and the filter cake was washed with a mixed solution of acetic acid and water (volume ratio of both 1), dried in vacuo, and purified by chromatography to obtain 2- (4-bromophenyl) -1- (4-methoxyphenyl) -1H-phenanthro [9,10] imidazole (PhImBr, whose structural formula is specifically shown below), and the eluent was a mixed solvent of dichloromethane and petroleum ether (volume ratio of both 1.
Figure BDA0003785097570000121
(2) PhImBr (2 mmol), 9-dimethylacridine (2 mmol) and potassium tert-butoxide (6.9 mmol) were placed in a round-bottomed flask, xylene (30 mL) was added thereto, and they were mixed with stirring, and then nitrogen was introduced into the mixture for 1 hour. Under a nitrogen atmosphere, palladium (II) acetate (Pd (OAc) 2 (ii) a 0.1 mmol) and tri-tert-butylphosphine (P (tBu) 3 (ii) a 0.3 mmol) was added to the above reaction solution, and then the reaction was stirred at 130 ℃ overnight.
After the reaction was completed, it was cooled to room temperature, the precipitate was filtered off, and the filtrate was washed with brine, dried over anhydrous sodium sulfate, filtered and concentrated to dryness. The resulting solid was purified by chromatography, silica gel (eluent: a mixed solvent of ethyl acetate and n-hexane in a volume ratio of 1: 5) to give 2- (4- (9, 9-dimethylacridin-10 (9H) -yl) phenyl) -1-4-methoxyphenyl) -1H-phenanthro [9,10] imidazole (PhImAc) as compound I.
The obtained compound I is subjected to mass spectrometry, and the flight time mass spectrum data thereof are as follows: m/z (%) 607.26 (100) [ M ] + ]。
The obtained compound I is tested by ultraviolet spectrum and fluorescence spectrum, and the test spectrogram is shown in figure 1.
The thermogravimetric analysis spectrum of the compound I is shown in FIG. 3, and the cracking temperature is 315 ℃.
(3) An electroluminescent blue-ray device is prepared by taking the obtained mixture of the compound I and bis [2- ((oxo) diphenylphosphino) phenyl ] ether (DPFPO) as a luminescent layer material, and the method is as follows:
1. putting the glass or plastic substrate cleaned by deionized water into a vacuum evaporation plating instrument for evaporation plating, wherein the vacuum degree is 1 multiplied by 10 -6 mbar, evaporation rate set at 0.1nm s -1 The evaporation material is Indium Tin Oxide (ITO) to obtain an anode conducting layer with the thickness of 10 nm;
2. evaporating a hole injection layer material MoOx on the anode conducting layer to obtain a hole injection layer with the thickness of 10 nm;
3. evaporating a hole transport layer material 9,9' - (1, 3-phenyl) di-9H-carbazole (mCP) on the hole injection layer to obtain a hole transport layer with the thickness of 40 nm;
4. and (3) evaporating a luminescent layer material on the hole transport layer: the material of the luminescent layer is a mixture of a compound I and DPFPO, wherein the mass fraction of the DPFPO is 20 percent, and the luminescent layer with the thickness of 50nm is obtained;
5. continuously evaporating DPFPO on the luminescent layer to obtain an electron transport layer with the thickness of 40 nm;
6. evaporating and plating an electron injection layer material LiF on the electron transport layer, wherein the thickness of the electron injection layer is 10 nm;
7. and evaporating a cathode conducting layer which is made of aluminum and has the thickness of 10nm on the electron injection layer to obtain the electro-blue light device 1.
The structure of the electric blue light device 1 in the embodiment is as follows: ITO/MoOx (10 nm)/mcp (40 nm)/(I) DPFPO (20%) 50 nm/(I) (40 nm)/LiF (10 nm)/Al.
Example 2
(1) Compound II (2- (4- (9, 9-diphenylacridin-10 (9H) -yl) phenyl) -1- (4-methoxyphenyl) -1H-phenanthro [9,10-d ] imidazole) was prepared according to the method in example 1, with the exception that: the 9, 9-dimethylacridine was replaced with an equimolar amount of 9, 9-diphenylacridine.
And carrying out mass spectrum test on the obtained compound II, wherein the flight time mass spectrum data of the compound II are as follows: m/z (%) < 731.29 (100) [ M ] + ];
And testing the obtained compound II by ultraviolet spectrum and fluorescence spectrum, wherein the test spectrogram is shown in figure 2.
The thermogravimetric analysis spectrum of the compound II is shown in FIG. 4, and the cracking temperature is 454 ℃ as shown in the graph.
(2) According to the preparation method of the blue electroluminescent device in example 1, a mixture of the compound ii and DPFPO (wherein, the mass fraction of DPFPO is 20%) is used as a luminescent layer material to prepare a blue electroluminescent device 2. The structure is as follows: ITO/MoOx (10 nm)/mcp (40 nm)/(II) DPFPO (20%) 50 nm/(II) (40 nm)/LiF (10 nm)/Al.
Examples of the experiments
Experimental example 1
Fig. 5 and 6 show voltage-luminance relationship curves of the blue electroluminescent device 1-2 prepared in test example 1-2, and it can be seen that the blue electroluminescent device 1-2 prepared in example 1-2 has a turn-on voltage of 4.1V and a turn-on voltage of 3.3V, respectively.
Experimental example 2
As shown in fig. 7 and 8, the luminance-current efficiency relationship curves of the electro-blue light device 1-2 prepared in test example 1-2 show:
the electroluminescent blue light device 1 has a luminance of 532cd m -2 When the current efficiency reaches the maximum value of 3.65 cd.A -1
The blue electroluminescent device 2 has a brightness of 642cd m -2 When the current efficiency reaches the maximum value of 2.30 cd.A -1
Experimental example 3
As shown in fig. 9 and 10, the luminance-power efficiency relationship curves of the blue electroluminescent device 1-2 prepared in test example 1-2 were confirmed,
the electroluminescent blue light device 1 has a luminance of 532cd m -2 When the power efficiency reaches the maximum value of 2.01 lm.W -1
The electroluminescent blue light device 2 has a luminance of cd m -2 When the power efficiency reaches the maximum value of 1.32 lm.W -1
Experimental example 4
As shown in fig. 11 and 12, the luminance-external quantum efficiency relationship curves of the blue electroluminescent devices prepared in test examples 1-2 were confirmed,
the electroluminescent blue light device 1 has a luminance of 532cd m -22 Then, the maximum external quantum efficiency of 3.68% was obtained.
The blue electroluminescent device 2 has a brightness of 642cd m -2 Then, the maximum external quantum efficiency of 2.50% is obtained.
Experimental example 5
The electroluminescence spectra of the electroluminescent blue device 1-2 prepared in test example 1-2 are shown in fig. 13 and 14, respectively.
From the above data, the electroluminescence peaks of the electro-blue device prepared in example 1-2 were at 431 and 414nm, respectively.
The invention has been described in detail with reference to specific embodiments and/or illustrative examples and the accompanying drawings, which, however, should not be construed as limiting the invention. Those skilled in the art will appreciate that various equivalent substitutions, modifications or improvements may be made to the embodiments and implementations of the invention without departing from the spirit and scope of the invention, and are within the scope of the invention. The scope of the invention is defined by the appended claims.

Claims (10)

1. A luminescent layer of an electroluminescent device is characterized in that the luminescent layer is prepared by taking one or more of acridine phenyl phenanthroimidazole compounds as raw materials,
the acridine phenyl phenanthroimidazole compound is selected from compounds having the following structures:
Figure FDA0003785097560000011
wherein R is 1 、R 2 Each independently selected from hydrogen, phenyl or alkyl, preferably from hydrogen, phenyl or a carbon containing number C 1 -C 5 More preferably phenyl or methyl;
preferably, the raw material of the light emitting layer further includes bis [2- ((oxo) diphenylphosphino) phenyl ] ether (DPEPO).
2. An acridinophenylphenanthoimidazole compound characterized by the following structure:
Figure FDA0003785097560000012
wherein R is 1 、R 2 Each independently selected from hydrogen, phenyl or alkyl, preferably from hydrogen, phenyl or a carbon containing number C 1 -C 5 More preferably phenyl or methyl.
3. The compound according to claim 2, wherein said acridinophenylphenanthoimidazole compound is selected from the group consisting of:
Figure FDA0003785097560000021
4. a preparation method of an acridine phenyl phenanthroimidazole compound is characterized by taking an acridine compound and halogenated phenyl phenanthroimidazole as raw materials, and carrying out catalytic coupling to prepare the acridine phenyl phenanthroimidazole compound.
5. The method according to claim 4, wherein the halophenylphenanthroimidazole is 2- (4-halo-phenyl) -1- (4-methoxyphenyl) -1H phenanthro [9,10] imidazole, which is:
Figure FDA0003785097560000022
wherein, X is a halogenated group, preferably bromo, iodo or chloro, more preferably bromo.
6. The method according to claim 4, characterized in that it comprises in particular the steps of:
step 1, phenanthrene-9, 10-diketone, 4-methoxyaniline and 4-halogenated-benzaldehyde are added into a solvent I and subjected to condensation cyclization reaction to obtain 2- (4-halogenated-phenyl) -1- (4-methoxyphenyl) -1H phenanthro [9,10] imidazole;
step 2, adding 2- (4-halogenated-phenyl) -1- (4-methoxyphenyl) -1H phenanthro [9,10] imidazole and acridine compounds into a solvent II, and carrying out catalytic coupling reaction to obtain a reaction solution;
and 3, post-treating the reaction liquid to obtain the acridine phenyl phenanthroimidazole compound.
7. The method according to claim 6, wherein in step 1, the 2- (4-halo-phenyl) -1- (4-methoxyphenyl) -1H phenanthro [9,10] imidazole is prepared by condensation ring formation of phenanthrene-9, 10-dione, 4-methoxyaniline and 4-halo-benzaldehyde under acidic conditions;
the 4-halo-benzaldehyde is selected from 4-bromobenzaldehyde, 4-chlorobenzaldehyde or 4-iodo-benzaldehyde, and is preferably 4-bromobenzaldehyde;
the condensation cyclization reaction is carried out in an acidic solution, and weakly acidic substances, such as ammonium acetate and acetic acid, are added into the reaction solution.
8. The method according to claim 4, wherein in step 2, the acridine compound is selected from acridine or 9, 9-disubstituted acridine, wherein in the 9, 9-disubstituted acridine, the substituent is selected from phenyl or alkyl, preferably selected from phenyl or carbon number C 1 -C 5 More preferably phenyl or methyl;
the molar ratio of the- (4-halogenated-phenyl) -1- (4-methoxyphenyl) -1H phenanthro [9,10] imidazole to the acridine compound is 1 (0.6-2.3), preferably 1 (0.8-1.8), and more preferably 1 (1.0-1.3).
9. The method according to claim 3, wherein in step 2, the solvent II is selected from one or more of amide solvents, ketone solvents and aromatic solvents, preferably from one or more of N, N-Dimethylformamide (DMF), N-Dimethylacetamide (DMA), toluene, xylene, 1, 3-dimethyl-2-imidazolidinone (DMI) and cyclohexanone, and more preferably from xylene;
the molar volume ratio of the acridine compound to the solvent II is 2mmol (15-45) mL, preferably 2mmol (20-40) mL, and more preferably 2mmol (25-35) mL.
10. An application of acridine phenyl phenanthroimidazole compound as luminescent layer material in preparing electroluminescent device.
CN202210939882.2A 2022-08-05 2022-08-05 Acridine phenyl phenanthroimidazole compound for preparing luminescent layer of electroluminescent device and preparation method thereof Pending CN115724825A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210939882.2A CN115724825A (en) 2022-08-05 2022-08-05 Acridine phenyl phenanthroimidazole compound for preparing luminescent layer of electroluminescent device and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210939882.2A CN115724825A (en) 2022-08-05 2022-08-05 Acridine phenyl phenanthroimidazole compound for preparing luminescent layer of electroluminescent device and preparation method thereof

Publications (1)

Publication Number Publication Date
CN115724825A true CN115724825A (en) 2023-03-03

Family

ID=85292691

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210939882.2A Pending CN115724825A (en) 2022-08-05 2022-08-05 Acridine phenyl phenanthroimidazole compound for preparing luminescent layer of electroluminescent device and preparation method thereof

Country Status (1)

Country Link
CN (1) CN115724825A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108530357A (en) * 2017-03-03 2018-09-14 中国科学院宁波材料技术与工程研究所 Acridine D-A type thermal activation delayed fluorescence material, preparation method and application
CN110305107A (en) * 2018-03-27 2019-10-08 武汉尚赛光电科技有限公司 Thermotropic delayed fluorescence material with phenanthro- glyoxaline structure and its preparation method and application
CN111333615A (en) * 2018-12-19 2020-06-26 三星显示有限公司 Heterocyclic compound and organic light-emitting device including the same
CN113563314A (en) * 2021-07-13 2021-10-29 广东工业大学 Phenanthroimidazole derivative and preparation method and application thereof
CN114773317A (en) * 2022-05-18 2022-07-22 山东科技大学 Donor-acceptor type organic blue light material, preparation method and application thereof, and electroluminescent device

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108530357A (en) * 2017-03-03 2018-09-14 中国科学院宁波材料技术与工程研究所 Acridine D-A type thermal activation delayed fluorescence material, preparation method and application
CN110305107A (en) * 2018-03-27 2019-10-08 武汉尚赛光电科技有限公司 Thermotropic delayed fluorescence material with phenanthro- glyoxaline structure and its preparation method and application
CN111333615A (en) * 2018-12-19 2020-06-26 三星显示有限公司 Heterocyclic compound and organic light-emitting device including the same
CN113563314A (en) * 2021-07-13 2021-10-29 广东工业大学 Phenanthroimidazole derivative and preparation method and application thereof
CN114773317A (en) * 2022-05-18 2022-07-22 山东科技大学 Donor-acceptor type organic blue light material, preparation method and application thereof, and electroluminescent device

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DONG YUEL KWON: "Theoretical Study of Imidazole Derivatives for Blue Thermally Activated Delayed Fluorescence Emitter", J. NANOSCI. NANOTECHNOL, vol. 16, no. 10, pages 11014 *
SHENGBING XIAO: "Efficient and stable deep-blue narrow-spectrum electroluminescence based on hybridized local and charge-transfer (HLCT) state", DYES AND PIGMENTS, vol. 193, pages 109482 *
ZHI HUANG: "Highly twisted bipolar emitter for efficient nondoped deep-blue electroluminescence", DYES AND PIGMENTS, vol. 140, pages 328 - 336, XP029921062, DOI: 10.1016/j.dyepig.2017.01.028 *

Similar Documents

Publication Publication Date Title
JP6869402B2 (en) Nitrogen-containing compounds, organic electroluminescence devices and photoelectric conversion devices
CN110862381B (en) Organic electroluminescent compound and preparation method and application thereof
EP1902013B1 (en) Novel anthracene derivatives, process for preparation thereof, and organic electronic light emitting device using the same
JP5638612B2 (en) Novel heterocyclic derivative and organic light emitting device using the same
JP7251711B2 (en) organic light emitting device
TW201038576A (en) Materials for organic electroluminescent devices
He et al. Asymmetrically twisted anthracene derivatives as highly efficient deep-blue emitters for organic light-emitting diodes
KR101132462B1 (en) New anthracene derivatives and organic electronic device using the same
TW200812936A (en) Anthracene derivatives, organic electronic devices using anthracene derivatives, and electronic apparatuses comprising organic electronic device
WO2021082714A1 (en) Nitrogen-containing compound, electronic component and electronic device
KR20210002670A (en) Organic electroluminescent materials and devices
CN112979687A (en) Thermal activation delayed fluorescent material and preparation method and application thereof
JPWO2007026846A1 (en) Arylamine compound and organic electroluminescence device
KR102657637B1 (en) Anthracene compound, coating composition and organic light emitting device comprising same
CN113121584A (en) Heterocyclic compound and organic electroluminescent device comprising same
WO2023241569A1 (en) Aza-adamantane compound and organic electroluminescent element
KR102615340B1 (en) Organic electroluminescent material, method for producing the same, and organic electroluminescent device
TWI387575B (en) Synthesis of triphenylene and pyrene based aromatics and their application in oleds
JP2007246468A (en) Fluorene compound and organic electroluminescent element using the same
KR20200011911A (en) Multicyclic compound and organic light emitting device comprising the same
KR101434726B1 (en) Anthracene derivative and organic electroluminescence device using the same
KR102657636B1 (en) Anthracene compound, coating composition and organic light emitting device comprising same
CN115724825A (en) Acridine phenyl phenanthroimidazole compound for preparing luminescent layer of electroluminescent device and preparation method thereof
CN110305112B (en) Organic photoelectric material and application thereof
KR20210062496A (en) Compound for organic optoelectronic and organic optoelectronic device including the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination